Karim Nazer, MD
Infectious Disease · Florence, SCNPI 1174613004
Payments from drug & device makers
Across 23 payments — averaging $21.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Cordis US CORP.$61
- Merck$59
- Johnson & Johnson$54
- Shionogi Inc$54
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$45
- Insmed, Inc.$28
- plus $185 from 9 others
What the payments were for
- Food & beverage$486100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Cordis US CORP. | 2 | $61 |
| Merck | 4 | $59 |
| Johnson & Johnson | 3 | $54 |
| Shionogi Inc | 2 | $54 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $45 |
| Insmed, Inc. | 1 | $28 |
| Smith+Nephew | 1 | $27 |
| Astellas Pharma US Inc | 1 | $23 |
| AbbVie | 1 | $23 |
| Mallinckrodt Hospital Products Inc. | 1 | $23 |
| Novartis | 1 | $21 |
| Amgen | 1 | $19 |
| Otsuka America Pharmaceutical, Inc. | 1 | $18 |
| Alkermes, Inc. | 1 | $17 |
| Tetraphase Pharmaceuticals, Inc. | 1 | $15 |
How this compares
$486 in reported general payments places this provider in the 35th percentile of 102 infectious disease providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Divalproex Sodium | 11 | $280 |
| EliquisApixaban | 11 | $246 |
| Potassium Chloride | 17 | $208 |
| CeftriaxoneCeftriaxone Sodium | 17 | $186 |
| Levothyroxine Sodium | 29 | $164 |
| Sodium Chloride0.9 % Sodium Chloride | 15 | $147 |
| Gabapentin | 16 | $115 |
| Cefdinir | 17 | $88 |
| Carvedilol | 15 | $87 |
| Escitalopram Oxalate | 15 | $86 |
| Doxycycline Hyclate | 18 | $74 |
| Fluoxetine Hcl | 16 | $67 |
| Atorvastatin Calcium | 11 | $65 |
| Furosemide | 13 | $64 |
Paid to pharmacies, not to this prescriber.
Other infectious disease in Florence
- Rishika MotianiFlorence$43K
- Julio ArroyoFlorence$5K
- Temujin ChavezFlorence$3K
- Ramesh BharadwajFlorence$1K
- Timothy HenkelHilton Head Island$1.8M
- Eric MeissnerCharleston$1.6M
- John McKinnonCharleston$934K
- Kent StockCharleston$881K
- Edwin HayesColumbia$602K
- Divya AhujaColumbia$291K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.